These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 9042270

  • 1. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP, Baxevanis CN, Papadopoulos NG, Zarkadis IK, Papacostas P, Michailakis E, Tsiatas ML, Papamichail M.
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [Abstract] [Full Text] [Related]

  • 2. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G, Gückel B, Wallwiener D, Moldenhauer G.
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [Abstract] [Full Text] [Related]

  • 3. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 4. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Cannon MJ, Parham GP.
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [Abstract] [Full Text] [Related]

  • 5. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
    Blanchard DK, Kavanagh JJ, Sinkovics JG, Cavanagh D, Hewitt SM, Djeu JY.
    Cancer Res; 1988 Nov 15; 48(22):6321-7. PubMed ID: 2972357
    [Abstract] [Full Text] [Related]

  • 6. Intrapleural application of natural IFN alpha in breast cancer patients with pleural carcinomatosis. Monitoring of immunotherapy by assaying serum interferon levels.
    Mazuran R, Ikić-Sutlić M, Jereb B, Stabuc B, Krasovec MU, Cerar O, Soos E.
    J Biol Regul Homeost Agents; 1992 Nov 15; 6(2):46-52. PubMed ID: 1414464
    [Abstract] [Full Text] [Related]

  • 7. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T, Matsumoto K, Kuroki H, Kubo M, Baba E, Onishi H, Tasaki A, Nakamura M, Inaba S, Katano M.
    Anticancer Res; 2003 Nov 15; 23(6a):4459-65. PubMed ID: 14666734
    [Abstract] [Full Text] [Related]

  • 8. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Li DJ.
    Zhonghua Zhong Liu Za Zhi; 1989 Jul 15; 11(4):294-6. PubMed ID: 2625114
    [Abstract] [Full Text] [Related]

  • 9. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A, Klein E.
    J Natl Cancer Inst; 1986 Mar 15; 76(3):389-98. PubMed ID: 2419621
    [Abstract] [Full Text] [Related]

  • 10. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ, Cai QC, Shi YX, Lin XB, Wei J, Guo Y, Pan ZH.
    Ai Zheng; 2006 Aug 15; 25(8):1023-8. PubMed ID: 16965687
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.
    Baxevanis CN, Dedoussis GV, Gritzapis AD, Stathopoulos GP, Papamichail M.
    Br J Cancer; 1994 Oct 15; 70(4):625-30. PubMed ID: 7917907
    [Abstract] [Full Text] [Related]

  • 13. Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity.
    Amirghofran Z, Sheikhi AK, Kumar PV, Saberi Firouzi M.
    J Cancer Res Clin Oncol; 2002 Aug 15; 128(8):443-8. PubMed ID: 12200601
    [Abstract] [Full Text] [Related]

  • 14. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B, Portalès P, Thanh AD, Merlet S, Dereure O, Clot J, Corbeau P.
    Br J Dermatol; 2005 Apr 15; 152(4):690-6. PubMed ID: 15840100
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA, Ehya H, Lang WR.
    Acta Cytol; 1987 Apr 15; 31(4):448-52. PubMed ID: 3604540
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.
    Urol Oncol; 2009 Apr 15; 27(6):598-603. PubMed ID: 18818106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
    Chang GC, Lan HC, Juang SH, Wu YC, Lee HC, Hung YM, Yang HY, Whang-Peng J, Liu KJ.
    Cancer; 2005 Feb 15; 103(4):763-71. PubMed ID: 15637694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.